Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.62 | N/A |
PEG Ratio (TTM) | 1.14 | N/A |
P/S Ratio (TTM) | 0.73 | N/A |
P/B Ratio (TTM) | 0.44 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | -83.60 | N/A |
Price to 5YR AVG FCF Ratio | 62.67 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.12% | N/A |
ROE (TTM) | -9.04% | N/A |
Net Profit Margin (TTM) | -15.14% | N/A |
ROIC 5YR AVG | -0.26% | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -23.28% | 28.96% | -23.94% |
Revenue | 1.91% | -16.65% | -16.05% |
Net Income | -62.79% | 28.94% | -22.68% |
Cash Flow | -25.00% | -23.19% | -19.42% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.31 | N/A |
Quick Ratio (TTM) | 3.31 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 1.09 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | -2.40% | N/A |